• chevron_right

      Ancient Egyptian followers of a deity called Bes may have used hallucinogens

      news.movim.eu / ArsTechnica · Wednesday, 14 June, 2023 - 21:56 · 1 minute

    Drinking vessel in shape of Bes head

    Enlarge / An Egyptian drinking vessel in the shape of Bes head contained traces of Syrian rue and blue water lily, among other compounds. (credit: Tampa Museum of Art, Florida)

    An ancient Egyptian vase in the shape of the deity Bes showed traces of chemical plant compounds known to produce hallucinations, according to a recent preprint posted to Research Square. The authors suggest that members of the cult of Bes may have consumed a special cocktail containing the compounds to induce altered states of consciousness.

    There is ample evidence that humans in many cultures throughout history used various hallucinogenic substances in religious ceremonies or shamanic rituals. That includes not just ancient Egypt but also ancient Greek, Vedic, Maya, Inca, and Aztec cultures. The Urarina people who live in the Peruvian Amazon Basin still use a psychoactive brew called ayahuasca in their rituals, and Westerners seeking their own brand of enlightenment have also been known to participate.

    Lacing the beer served at their feasts with hallucinogens may have helped an ancient Peruvian people known as the Wari forge political alliances and expand their empire, according to a 2022 study . As previously reported , the use of hallucinogens, particularly a substance derived from the seeds of the vilca tree, was common in the region during the so-called Middle Horizon period, when the Wari empire thrived.

    Read 9 remaining paragraphs | Comments

    • chevron_right

      New mechanism proposed for why some psychedelics act as antidepressants

      news.movim.eu / ArsTechnica · Friday, 17 February, 2023 - 16:11

    Image of a multi-color, iridescent mushroom.

    Enlarge (credit: VICTOR de SCHWANBERG/SCIENCE PHOTO LIBRARY )

    Psychedelic drugs are often used for entertainment purposes. But there have been some recent indications that they can be effective against PTSD and treatment-resistant depression. Figuring out whether these substances work as medicinal drugs can be challenging because (as one researcher helpfully pointed out) it's difficult to do a controlled experiment when it's easy to figure out who's in the treatment group. Still, we've made some progress in understanding what's happening with psychedelics at the molecular level.

    Many psychedelics seem to bind to a specific receptor for the neural signaling molecule serotonin, activating it. That would seem to make sense for antidepressive effects, given that many popular antidepressants also alter serotonin signaling (such as in SSRIs, or selective serotonin reuptake inhibitors). But SSRIs don't produce any of the mind-altering effects that drive non-medical interest in psychedelics, so things remain a bit confusing.

    New data suggests that psychedelics may activate serotonin signaling in a very different way than serotonin itself can, reaching the receptors in parts of the cell that serotonin can't get to.

    Read 11 remaining paragraphs | Comments